Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.
作者信息
Hung Anna, Growdon Matthew E
机构信息
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
Duke-Margolis Institute for Health Policy, Durham, North Carolina, USA.
出版信息
J Am Geriatr Soc. 2025 Feb;73(2):343-346. doi: 10.1111/jgs.19294. Epub 2024 Nov 26.
Abstract
摘要
相似文献
1
Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.
J Am Geriatr Soc. 2025 Feb;73(2):343-346. doi: 10.1111/jgs.19294. Epub 2024 Nov 26.
2
Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
J Am Geriatr Soc. 2024 Jul;72(7):1973-1984. doi: 10.1111/jgs.18867. Epub 2024 Mar 15.
3
Central Nervous System Polypharmacy Among People Living With Dementia.
J Am Med Dir Assoc. 2025 Aug;26(8):105708. doi: 10.1016/j.jamda.2025.105708. Epub 2025 Jun 14.
4
Deprescribing tools and guidelines in chronic kidney disease: A scoping review.
Res Social Adm Pharm. 2025 Sep;21(9):679-686. doi: 10.1016/j.sapharm.2025.05.005. Epub 2025 May 9.
5
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study.
Drugs Aging. 2025 Mar;42(3):257-265. doi: 10.1007/s40266-024-01178-x. Epub 2025 Jan 20.
6
A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia.
BMC Geriatr. 2022 Mar 16;22(1):214. doi: 10.1186/s12877-022-02914-x.
7
The value of deprescribing in older adults with dementia: a narrative review.
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
8
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis.
J Am Geriatr Soc. 2024 Oct;72(10):3219-3238. doi: 10.1111/jgs.19035. Epub 2024 Jun 1.
9
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools.
Expert Rev Clin Pharmacol. 2025 Jun;18(6):333-345. doi: 10.1080/17512433.2025.2519648. Epub 2025 Jun 13.
10
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
本文引用的文献
1
Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States.
J Am Geriatr Soc. 2025 Feb;73(2):422-430. doi: 10.1111/jgs.19256. Epub 2024 Nov 5.
2
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
3
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.
J Am Geriatr Soc. 2023 Jul;71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4.
4
Attitudes toward deprescribing among older adults with dementia in the United States.
J Am Geriatr Soc. 2022 Jun;70(6):1764-1773. doi: 10.1111/jgs.17730. Epub 2022 Mar 10.
5
Polypharmacy among older adults with dementia compared with those without dementia in the United States.
J Am Geriatr Soc. 2021 Sep;69(9):2464-2475. doi: 10.1111/jgs.17291. Epub 2021 Jun 8.
6
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
JAMA. 2021 Mar 9;325(10):952-961. doi: 10.1001/jama.2021.1195.
7
Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US.
JAMA. 2020 Aug 18;324(7):706-708. doi: 10.1001/jama.2020.8519.
8
Barriers and facilitators to deprescribing in primary care: a systematic review.
BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101096. Print 2020 Aug.
9
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.
J Manag Care Spec Pharm. 2020 Feb;26(2):169-175. doi: 10.18553/jmcp.2020.26.2.169.
10
Association Between Medications Acting on the Central Nervous System and Fall-Related Injuries in Community-Dwelling Older Adults: A New User Cohort Study.
J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):1003-1009. doi: 10.1093/gerona/glz270.
Zotero 插件